# Neuromodulation for Hypothalamic Obesity

> **NCT03708913** · NA · WITHDRAWN · sponsor: **University of British Columbia**

## Conditions studied

- Craniopharyngioma
- Hypothalamic Obesity
- Metabolic Syndrome

## Interventions

- **DEVICE:** Hypothalamic Deep Brain Stimulation

## Key facts

- **NCT ID:** NCT03708913
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-06-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2020-04-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no participants have been able to qualify for study
- **Last updated:** 2020-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03708913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03708913, "Neuromodulation for Hypothalamic Obesity". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03708913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*